zh-twzhen
zh-twzhen

NEWS

合一生技股份有限公司 / 2023 / Oneness Biotech Co., Ltd. receives the United States patent on the producing recombinant glycoproteins with modified glycosylation.

Oneness Biotech Co., Ltd. receives the United States patent on the producing recombinant glycoproteins with modified glycosylation.

2023-06-01

Published Date:2023-06-01

Original Link:https://www.onenessbio.com/en/news_detail223_3.htm

No 1 Date of announcement 2023/06/01 Time of announcement  17:35:53
Subject Oneness Biotech Co., Ltd. receives the United States patent on the producing recombinant glycoproteins with modified glycosylation.
To which item it meets paragraph 53 Date of events 2023/06/01
Statement
  1. Date of occurrence of the event:2023/06/01
  2. Company name:ONENESS BIOTECH CO., LTD.
  3. Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office
  4. Reciprocal shareholding ratios:NA
  5. Cause of occurrence:The Company has been informed by the patent agency that the methods for glycan modification on recombinant protein, has been granted the United States patent entitled ”METHODS FOR PRODUCING RECOMBINANT GLYCOPROTEINS WITH MODIFIED GLYCOSYLATION”under the patent number US 11,439,682 B2.
  6. Countermeasures:None
  7. Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):None